On the 8th March 2019 NHS England published a guidance document for patients with Type 1 Diabetes setting out the eligibility criteria for flash glucose monitoring.
Following release of this guidance, the Staffordshire & Stoke on Trent Clinical Commissioning Groups (CCGs) have been working with Diabetes Specialist Teams to put in an appropriate pathway to make sure that eligible patients have access to the glucose monitoring device.
Whilst the National media reported that Flash Glucose Monitoring systems would be available from the 1st April 19 it is the intention of the CCG to offer access to this provision from the 1st May as the guidelines and funding arrangements were published later than expected.
Dr John Gilby, Clinical Director for the CCGs said, “We are delighted that we national funding has been made available to help Type 1 diabetics who meet the criteria to better manage their condition and spot the early signs that they need to take appropriate action. Type 1 diabetes causes the level of glucose (sugar) in the blood to become too high. It happens when the body can't produce enough of a hormone called insulin, which controls blood glucose and the long term consequences of it not being controlled can be very serious”.
Patients who do not meet the criteria set out by NHS England and wish to self-fund can still purchase the product. Further information is available from Abbott via the following link: https://www.freestylelibre.co.uk/libre/products.html
The eligibility criteria can be accessed at https://www.england.nhs.uk/publication/flash-glucose-monitoring-national-arrangements-for-funding-of-relevant-diabetes-patients/